PCR isolation and cloning of novel splice variant mRNAs from known drug target genes

Genomics

Volumn 83, Issue 4, 2004, Pages 566-571

  Jin, Pei ^a   Fu, Glenn K ^a   Wilson, Amy D ^a   Yang, Junming ^a   Chien, David ^a   Hawkins, Phillip R ^a   Au Young, Janice ^a   Stuve, Laura L ^a  

^a Experimental Station   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ISOLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; STATISTICAL SIGNIFICANCE; UNINDEXED SEQUENCE;

ALTERNATIVE SPLICING; CLONING, MOLECULAR; DNA, COMPLEMENTARY; EXPRESSED SEQUENCE TAGS; GENOME, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; PHARMACEUTICAL PREPARATIONS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

VERTEBRATA;

EID: 1542613791     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygeno.2003.09.023     Document Type: Article

References (16)

1. Roest Crollius H. Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence. Nat. Genet. 25:2000;235-238.
2. Liang F.et al. Gene index analysis of the human genome estimates approximately 120,000 genes. Nat. Genet. 25:2000;239-240.
3. Brett D.et al. EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett. 474:2000;83-86.
4. Mironov A.A., Fickett J.W., Gelfand M.S. Frequent alternative splicing of human genes. Genome Res. 9:1999;1288-1293.
5. Kan Z., Rouchka E.C., Gish W.R., States D.J. Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res. 11:2001;889-900.
6. Croft L.et al. ISIS, the intron information system, reveals the high frequency of alternative splicing in the human genome. Nat. Genet. 24:2000;340-341.
7. Lander E.S.et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
8. Modrek B., Lee C. A genomic view of alternative splicing. Nat. Genet. 30:2002;13-19.
9. Brett D., Pospisil H., Valcarcel J., Reich J., Bork P. Alternative splicing and genome complexity. Nat. Genet. 30:2002;29-30.
10. Sorek R., Amitai M. Piecing together the significance of splicing. Nat. Biotechnol. 19:1999;196.
11. Wang Z.et al. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res. 63:2003;655-657.
12. Cartegni L., Krainer A.R. Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat. Struct. Biol. 10:2003;120-125.
13. Drews J., Ryser S. The role of innovation in drug development, Nat. Biotechnol. 15:1997;1318-1319.
14. Hardman J.G., Limbird L.E. The Pharmacological Basis of Therapeutics. 2001;McGraw-Hill, New York.
15. Florea L., Hartzell G., Zhang Z., Rubin G.M., Miller W. A computer program for aligning a cDNA sequence with a genomic DNA sequence. Genome Res. 8:1998;967-974.
16. Xu Q., Modrek B., Lee C. Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res. 30:2002;3754-3766.